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Magnetic Resonance Imaging (MRI) has become one of the most successful diagnostic 
imaging modalities. A large number of MRI scans use paramagnetic contrast agents (CA), to 
enhance the image’s contrast. Gd(III), with seven unpaired electrons and a long electronic 
relaxation time, is the most used metal ion for the preparation of CA. Mn(II) is also a good 
candidate for MRI contrast agents due to its five unpaired d electrons, a favorable electronic 
relaxation time, and the lability of the coordinated water molecule(s). Presently, there is one 
approved Mn(II)-based CA, Teslascan® ([MnDPDP]
4-
, DPDP
6-
 = N,N’-
dipyridoxylethylenediamine-N,N’-diacetate-5,5’-bis-(phosphate), Figure 1). 
Due to toxicity problems, the paramagnetic ions should be administrated as metal 
complexes of high thermodynamic and kinetic stabilities. Macrocyclic ligands are known to 
form such stable metal complexes. The presence of hydrophobic moieties in chelates allows 
them to bind to human serum albumin (HSA), the most abundant serum protein. The presence 
of binding sites with affinity for lipophilic groups [1] can be exploited as a strategy to 
increase the blood retention of the CA and also to enhance the relaxivity by increasing the 
tumbling time (τr) [2]. The formation of micelles can also be used with the goal of increasing 
the τr. Bifunctional ligands can be coupled to targeting molecules (i.e. peptides) with high 
affinity for biological receptors, preserving the coordination properties of the chalator. This 
consists in another strategy to target CA. 
In this work, we developed three new triazapolycarboxylate ligands for Mn(II), 
NODAHep (1,4,7-triazacyclononane-N,N’-diacetate-N’’-heptanil), NODABA (1,4,7-
triazacyclononane-N,N’-diacetate-N’’-bensoate), and NODAHA (1,4,7-triazacyclononane-
N,N’-diacetate-N’’-hexanoate) (Figure 1). These chelators are pentadentate, leaving one 
coordination site of the metal coordination sphere available for one water molecule. 
NODAHep has a lipophilic side chain, designed to endow the chelate with the capacity of 
forming micelles and of interacting non-covalently with HSA. This was expected to increase 
τr and consequently to increase the relaxivity. NODABA and NODAHA are bifunctional 
ligands that present a free carboxylic group in the pendant lateral chain, allowing their 
conjugation to targeting molecules. 
1
H NMRD and 
17
O NMR studies were performed for the three Mn(II) chelates, showing 
relaxivity values comparable to those of Gd(III) chelates with one water molecule in the inner 
coordination sphere of the metal ion. Potentiometric titrations allowed the determination of 
the pKa’s of the ligands and the thermodynamic stability constants of the Mn(II) and Zn(II) 
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chelates. The kinetic stability of [Mn(NODAHep)] in the presence of Zn(II) and at different 
pH values was also studied. The critical micellar concentration of the amphiphilic 
[Mn(NODAHep)] chelate was determined by fluorescence and 
1
H NMRD. 
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Figure 1 – Structure of the different chelators 
for Mn(II). 
